Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study proposes a prospective randomized controlled clinical trial involving primiparous women diagnosed with gestational diabetes mellitus (GDM) carrying singleton pregnancies. Participants will be randomized in a 1:1 ratio into either a control group or an intervention group.
The control group will receive standard prenatal care followed by routine postpartum breastfeeding guidance.
In addition to the standard care provided to the control group, the intervention group will receive one-on-one midwife-led manual breast milk expression training at the breastfeeding clinic. They will begin manual expression twice daily starting at 37 weeks gestation.
The primary outcome will compare exclusive breastfeeding rates at 3 months postpartum between groups through postpartum follow-up assessments to evaluate the impact of antenatal milk expression on breastfeeding success in GDM patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Antepartum Milk Expression Group | Active Comparator | Oarticipants will receive one-on-one antenatal breast milk expression instruction by a midwife and initiate twice-daily practice from 37 weeks gestation onward. |
|
| Control group | No Intervention | Participants will receive routine antenatal care and standard postpartum management |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| milk expression | Procedure | Following one-on-one antenatal manual colostrum expression instruction by a midwife at the breastfeeding clinic, participants will initiate twice-daily practice from 37 weeks gestation onward, performing 3-5 minutes of manual expression per breast per session (total duration ≤10 minutes per session). |
| Measure | Description | Time Frame |
|---|---|---|
| Exclusive breastfeeding rates at 3 months postpartum | 3 months postpartum |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Biologically female individuals capable of conception and childbirth
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ye Feng, M.D. | Contact | 8618001203634 | fengye_bjmu@163.com |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
Not provided
Not provided
prospective randomized controlled clinical trial
Not provided
Not provided
Not provided
Not provided
|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |